• Assay Designs (Ann Arbor, Michigan) reported two additions to its senior leadership team: Michael Mullenix, PhD, was named VP of R&D. Mullenix comes to Assay Designs from Amgen. Gabriella Szekely-Klepser, PhD, was named VP of science and technology. Assay Designs makes immunoassay kits, antibodies and reagents.

• Vinciane Gaussin, PhD, has been named chief scientific officer for Cardio³ BioSciences (Braine L’alleud, Belgium). Most recently, Gaussin was an assistant professor in the department of cell biology and molecular medicine at the University of Medicine and Dentistry of New Jersey (UMDNJ). Cardio³ is focused on regenerating heart muscle by using cardiac lineage-committed stem cell therapy for patients with congestive heart failure.

• Victoria Bradley, RN, has been named chief nursing informatics officer of Eclipsys (Boca Raton, Florida). Most recently, Bradley was the director of patient information for the University of Kentucky (Lexington, Kentucky). Eclipsys provides clinical, revenue cycle and access management software.

• Vincent Dadamo has been named general council of TMG Health (King of Prussia, Pennsylvania). Dadamo previously served as senior VP, general counsel and corporate secretary for ICT Group. TMG provides business processing outsourcing to Medicare and Medicaid managed care plans.